Forefront Analytics, LLC Dynavax Technologies Corp Transaction History

Forefront Analytics, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$7.25 - $10.99 $89,102 - $135,067	-12,290 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$4.57 - $11.18 $3,573 - $8,742	-782 Reduced 5.98%	12,290 $121,000
Q4 2020 Feb 12, 2021	SELL	$3.73 - $5.6 $15,404 - $23,128	-4,130 Reduced 24.01%	13,072 $58,000
Q3 2020 Nov 12, 2020	SELL	$4.32 - $11.7 $1,200 - $3,252	-278 Reduced 1.59%	17,202 $71,000
Q2 2020 Aug 10, 2020	BUY	$2.94 - $9.1 $51,391 - $159,068	17,480 New	17,480 $155,000

273

130M

451K

203K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.54B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Forefront Analytics, LLC, based on Form 13F filings with the SEC.

Stay updated on Forefront Analytics, LLC with notifications on news.